Mainstream

Harvard bioscience outlines q2 revenue target of $18m–$20m amid product launches and cost actions

Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions

Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions

Post ContenthbioRead More

You might also be interested in reading SEC Staff to Reassess Biden-Era Crypto Guidance Amid Regulatory Shakeup.

May 12, 2025
In Mainstream